Related Experiment Video
Updated: Jan 22, 2026
07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
Squamous cell lung cancer: genomic evolution and personalized therapy
Andrés F Cardona1,2,3, Luisa Ricaurte2, Zyanya Lucía Zatarain-Barrón4
1Grupo Oncología Clínica y Traslacional, Clínica del Country. Bogotá, Colombia.
Salud Publica De Mexico
|July 6, 2019
Summary
Squamous cell lung cancer (SCLC) affects over 400,000 people annually. Research is identifying molecular targets for new, more effective SCLC therapies.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Squamous cell lung cancer (SCLC) accounts for a significant portion of lung cancer diagnoses, despite being less common than adenocarcinoma.
- Over 400,000 new SCLC cases are reported globally each year, highlighting a critical need for improved treatment options.
Purpose of the Study:
- To provide a comprehensive review of the current knowledge regarding squamous cell lung cancer (SCLC).
- To detail the genetic anomalies associated with SCLC development and their implications.
- To identify and discuss promising therapeutic agents for SCLC treatment.
Main Methods:
- Systematic review of peer-reviewed scientific literature.
- Analysis of current treatment guidelines from national and international health organizations.
Main Results:
- SCLC, while less prevalent than lung adenocarcinoma, affects a substantial patient population worldwide.
- Current therapeutic options for SCLC are limited in efficacy.
- Ongoing research is focused on understanding the molecular underpinnings of SCLC to identify novel drug targets.
Conclusions:
- Emerging molecular targets show promise for SCLC treatment.
- Clinical trials are essential to validate the efficacy of these potential new therapies for squamous cell lung cancer.
Related Concept Videos
03:21Genome Size and the Evolution of New Genes
9.0K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.0K
03:21Genome Size and the Evolution of New Genes
3.3K
3.3K
02:02Genomics
39.8K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.8K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:49Cancer Therapies
9.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
02:55The Evidence for Evolution
47.7K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
47.7K